Affiliation:
1. Samara hospice
2. Yaroslavl State Medical University; First Moscow State Medical University named after I.M. S echenov
3. Yaroslavl State Medical University
Abstract
Adequate pain relief through individual tailoring of the basic analgesic in suited dose and drug formulation, as well as the use of adjuvant and supportive therapy, relieves the suffering of patients with advanced cancer in most cases. Noninvasive opioids in immediate and modified release formulations play a key role in treating severe chronic pain syndrome. We present a series of case studies to illustrate morphine tablet and oral solution administration as part of an individual pain therapy regimen, such as opioid dose titration, treatment of breakthrough pain, and around-the-clock pain control.
Reference7 articles.
1. Clinical guidelines "Chronic pain syndrome (CPS) in adult patients in need of palliative care" (approved by the Ministry of Health of the Russian Federation, 2023).
2. Olarte JM. Breakthrough cancer pain and rational drug use. Support Care Cancer. 2017 Apr;25 (Suppl 1):11-17. doi: 10.1007/s00520-017-3636-5.
3. Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI; ESMO Guidelines Committee. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018 Oct 1;29(Suppl 4):iv166-iv191. doi: 10.1093/annonc/mdy152.
4. Smith HS. Rapid onset opioids in palliative medicine. Ann Palliat Med. 2012 Apr;1(1):45-52. doi: 10.3978/j.issn.2224-5820.2012.01.01.
5. Zucco F, Bonezzi C, Fornasari D. Breakthrough cancer pain (BTcP): a synthesis of taxonomy, pathogenesis, therapy, and good clinical practice in adult patients in Italy. Adv Ther. 2014 Jul;31(7):657-82. doi: 10.1007/s12325-014-0130-z.